Understanding the regulatory contribution of maternal physiology to difficulties with lactation is beneficial to both mother and infant. MicroRNAs (miRNAs), a type of noncoding RNA, may be involved in the regulation of mammary gland development and function. In the present study, a deep RNA sequencing (RNA-seq) technique was used to compare the expression profile of miRNAs and mRNAs of 2 pooled RNA samples from day 1 and day 7 postpartum (n = 1/d) rat (Rattus norvegicus) mammary glands to identify key miRNAs and their target genes that may control the rate-limiting steps of lactation. A total of 395 and 400 known miRNAs were identified in days 1 and 7 postpartum rat mammary samples, respectively. Compared with day 1 postpartum, 27 miRNAs were differentially expressed at day 7 postpartum. The expression differences between lactation periods were further analyzed by real-time quantitative polymerase chain reaction (qPCR) (n = 5). The DDCt values of rno-miR-30, rno-miR-1, rno-miR-145-3p, rno-miR-142, rno-miR-7a-5p, rno-miR-3571, rnomiR-224-5p, rno-miR-362-5p, rno-miR-342-3p, rno-miR-322-3p, rno-miR-18a-5p, and rno-miR-202-5p between the 2 libraries varied from 0.64 to 9.44; the DDCt values of rno-miR-133, rno-miR-190a-5p, rno-miR-27a-5p, rno-miR-451-5p, rno-miR-3120, rno-miR-23a-5p, rno-miR-20a-3p, rno-miR-92a-1-5p, and rno-miR-134-5p between the 2 libraries varied from 21.02 to 24.37 (P < 0.05). The intersection of the expressed mRNA genes from RNA-seq and putative target genes of differentially expressed miRNAs, termed mammary gland target genes (MTGs), was analyzed. The results indicated that 1259 MTGs overlapped between the 2 gene sets. The expression of 14 randomly selected genes of the MTGs was further confirmed by real-time qPCR (R 2 = 0.86, P < 0.01). The downregulated MTGs were enriched for the pathways involved in lipid biosynthesis. This gene cluster included 24 lipid metabolic process-related genes, which were putative targets of 10 differentially expressed miRNAs. These results will be helpful in discovering the biologic underpinnings of poor lactation performance in women attempting to breastfeed.
Introduction
Breastfeeding is beneficial to both mother and infant. Milk provides not only a complete diet with all the essential nutrients but also essential immunologic protection for the neonate during the initial phase of life (1) . Moreover, immune factors in milk also play an important role in the host defense of the mammary gland itself, protecting it from pathogenic organisms (2) . Although most mothers initiate breastfeeding, difficulties with milk supply lead some to cease earlier than intended; however, the contribution of maternal physiology to lactation difficulties remains poorly understood (3) .
In an established mammary gland, cycles of proliferation, functional differentiation, and death of the alveolar epithelium occur repeatedly with each pregnancy (4, 5) . In the past few years, noncoding RNAs, particularly microRNAs (miRNAs), 5 have begun to be implicated in regulating mammary gland development and function (6) . Growing numbers of lactationrelated miRNAs have been identified and confirmed. Ten miRNAs were identified that achieved as much as a 98% knockdown of b-lactoglobulin, either individually or in tandem combinations (7) . Lactoferrin gene expression and function are directly targeted by miR-214 in HC11 cells (8) . miR-126-3p could inhibit expression of b-casein in mouse mammary epithelial cells (9) . miR-27a suppresses TG accumulation and affects gene mRNA expression associated with fat metabolism in dairy goat mammary gland epithelial cells (10) . Overexpression of miR-103 in mammary gland epithelial cells increases transcription of genes associated with milk fat synthesis (11) .
Mouse miRNA expression patterns have been characterized by microarrays as to be likely coregulated clusters during postnatal mammary gland development throughout juvenile, pubertal, mature virgin, gestational, lactation, and involution stages (12) . These studies also discovered that many miRNAs were differentially expressed during early lactation. RNA sequencing (RNA-seq) produced similar results, in that the expression of bovine miRNAs associated with transcriptional regulation of genes across diverse biologic functions was altered in the early stage of lactation (13) . Unfortunately, these studies paid more attention to the transition between different development stages, and little information on lactation was provided. Recently, the differential expression of the miRNAs between peak and late lactation in the dairy goat mammary gland was reported (14) . Taken together, several miRNAs might take part in the regulation of lactation. Therefore, we hypothesized that a number of lactation-related miRNAs remain undiscovered. However, studies of global patterns of miRNA expression during whole lactation are limited.
Given the impracticality and ethical concerns of obtaining systematic samples of mammary tissue from lactating women, the research into the biology of human lactation has to be based on rodent models. The rat is an important model animal for mammary biology and nutriology. However, no miRNA expression profile has been reported for its mammary gland to date. The objective of our study was to use RNA-seq to comprehensively identify miRNAs and their associated biologic pathways that are important in lactation in rats. We aimed to identify key miRNAs and their target genes that may control the rate-limiting steps of lactation and outline future work in an endeavor to discover the biologic underpinnings of poor lactation performance in women attempting to breastfeed.
Materials and Methods
Tissue collection. Sprague-Dawley rats (Rattus norvegicus) at the fifth gestation were obtained from Vital River Laboratories (Beijing, China). Rats were fed an AIN-93G diet during gestation and lactation (15) . Lactating mammary glands were harvested at days 1 and 7 postpartum. Five rats, designated as biologic replicates, were used per time point. Tissues were consistently collected at the same time of day to account for circadian effects. In each case, 1 complete inguinal gland was removed after excision of the intramammary lymph node; part of the liver was collected simultaneously. The samples were frozen in liquid nitrogen within 30 s after tissue dissection. Frozen samples were stored at 280°C until further analysis. The Review Committee for the Use of Animal Subjects of Jiangsu Normal University approved all the animal protocols.
RNA extraction. Trizol reagent (Invitrogen) was used to extract total RNA from each frozen sample, according to the manufacturerÕs protocol. RQ1 DNase (Promega) was used to treat the total RNA to remove DNA. An ND-2000c spectrophotometer (Fisher Thermo) and an Agilent 2100 bioanalyzer (Agilent Technologies) were used to confirm RNA quantity and integrity. Only samples with an RNA integrity number $7 were used for further miRNA expression analysis, and only samples with an RNA integrity number $8 were used for gene (mRNA) expression analysis. In the present study, all the samples passed the quality test.
Construction of mRNA and small RNA libraries for sequencing. The total RNA from days 1 and 7 postpartum mammary glands (n = 5) were mixed equally to make 2 pools representing the 2 lactation stages, respectively. For each pooled sample, 10 mg of total RNA was used for RNA-seq library preparation, and 3 mg of total RNA was used for small RNA (sRNA) cDNA library preparation. IlluminaÕs whole-transcriptome and sRNA sequencing protocols were used to prepare libraries for both whole-transcriptome sequencing and sRNA sequencing. The Illumina GAIIx system was used to perform sequencing runs for both wholetranscriptome sequencing and sRNA sequencing.
miRNA expression analysis. The raw reads of RNA-seq were processed into clean reads, and the ribosomal RNA, transfer RNA, small nuclear RNA, small cytoplasmic RNA, signal recognition particle RNA, and small nucleolar RNA sequences (16) were removed and the remaining reads mapped to the rat genome. Bowtie software (University of Maryland) (17) was used to compare the remaining reads of our data sets with the current release of miRBase (miRBase version 20.0; University of Manchester) to identify miRNAs. miRNA target prediction. The software miRanda (www.microrna.org; August 2010 release) (18, 19) was used to identify miRNA target genes (Memorial Sloan-Kettering Cancer Center, USA). Prediction scores were computed by using the miRanda database of highly conserved target sites with good miRNA support vector regression scores (19) . We chose this database because programs requiring target conservation across a broad range of species are more stringent than those with more relaxed definitions of conservation.
Gene expression analysis. After removing reads with adapters, reads in which unknown bases were >5%, and low-quality reads (we defined low-quality bases as those whose sequencing quality is no greater than 10), raw reads were filtered into clean reads. The clean reads were then aligned with the latest rat genome assembly (Rattus norvegicus Rnor_5.0). No more than 2 mismatches were allowed in the alignment.
Gene ontology and pathway enrichment analysis. The Database for Annotation, Visualization, and Integrated Discovery (DAVID) (17, 20) was used to identify overrepresented molecular functions based on Gene Ontology (GO) terms derived from the lists of putative target genes expressed in both mammary gland samples at the 2 time points. The false discovery rate (FDR) threshold for the GO terms was set at 0.05.
Real-time qPCR. To confirm our RNA-seq findings, real-time qPCR was used to randomly probe 14 mRNAs of interest and all 27 differentially expressed miRNA genes in the days 1 and 7 postpartum mammary glands (n = 5). The RNAs from each individual mammary gland were analyzed by qPCR. qPCR for mRNA genes was performed according to a previously described method (10) . The primer sequences are listed in Supplemental Table 1 . qPCR was also used to analyze the liver expression profile of selected putative target genes of differentially expressed miRNAs between the 2 lactating time points, which were identified by RNA-seq analysis of mammary glands.
A modified stem-loop TaqMan qPCR method (21) was used to confirm the sRNA sequencing results. The primers and specific probes for rno-miR-145-3p, rno-miR-30a-5p, and U6 small nuclear RNA were commercial TaqMan miRNA assays (Life Technology Corporation). The sequence of the universal stem-loop protocol TaqMan-based probe for the other miRNAs was 5#-FAM-TCGCACTGGATACG-MGBNFQ-3# (Life Technology Corporation), which was designed according to a recently published method (21) . The primer sequences for reverse transcription and quantifying miRNAs are listed in Supplemental Table 1 .
Statistical analysis. mRNA expression data were normalized by calculating the ''reads per kilo base per million mapped reads''
MicroRNAs regulate rat lactation 1143 (RPKM) for each mRNA gene (22) and annotated by using the National Center for Biotechnology Information rat genome assembly (Rnor_5.0). The expression of the miRNAs in 2 pools (day 1 and day 7 rat mammary gland tissues) was normalized to obtain the expression in transcripts per million (TPM). The gene expression profile correlation between the 2 pooled samples was analyzed to check their representation. The edgeR software package (Garvan Institute of Medical Research), which is based on a negative binomial model, was used to examine the differential expression of miRNAs and mRNAs (23) . To judge whether a gene was differentially expressed, the fold-change values (fold-change $2 or #0.5) and P values (P # 0.01) were used. The qPCR data for each differentially expressed miRNA were compared between lactation periods by t test. The linear regression between qPCR data of selected mRNA genes and the corresponding RNA-seq data were analyzed.
Results

Identification of known miRNAs and their putative targets.
A total of 5,968,928 and 6,389,374 raw reads were obtained from the days 1 and 7 lactation sRNA libraries, respectively. After removing the low-quality reads, adaptors, and insufficient tags, 2,335,257 and 2,145,192 clean reads of 18-30 nucleotides remained. Of the clean reads, 53% and 55% could be perfectly mapped to the National Center for Biotechnology Information rat genome assembly (Rnor_5.0), respectively. To assess the efficiency of high-throughput sequencing for sRNA detection, all sequence reads were annotated and classified by alignment with GenBank and Rfam databases. The classification annotation revealed that miRNAs account for 75% and 78% of the unique sRNAs in days 1 and 7 lactation periods, respectively.
In total, 36% and 38% of the clean reads matched perfectly to known animal miRNAs (number mismatch #1) deposited in miRBase 20.0. A total of 395 and 400 known miRNAs were identified in the day 1 and day 7 libraries, respectively. Most of the miRNAs (352) were coexpressed in the 2 libraries. The dynamic range of miRNA expression intensities covered several orders of magnitude: day 1, 0.27-317,581.50 TPM; day 7, 0.56-256,608.10 TPM (Supplemental Table 2 ). The total miRNA TPM value was also slightly lower in the day 7 mammary gland compared with that in the day 1 gland (Supplemental Table 2 ).
The top 10 miRNAs expressed at each stage are summarized in Table 1 . The top 10 expressed miRNAs at days 1 and 7 postpartum accounted for 70% and 69% of the mammary gland miRNAs, respectively. Remarkably, rno-miR-143-3p plus rno-miR-21-5p
represented 48% and 41% of days 1 and 7 postpartum mammary gland miRNAs, respectively. To investigate the functional role of these miRNAs in lactation, we predicted their gene targets. The top 10 miRNAs with an exact match to miRBase putatively targeted 3011 annotated genes. Enrichment analysis with the use of DAVID revealed 170 GO terms enriched at an FDR <0.05 (Supplemental Fig. 1 ). At both lactation stages, highly enriched GO terms were involved in plasma membrane, the Golgi apparatus, the endoplasmic reticulum, protein localization and transport within the cell, cellular ion homeostasis, and the regulation of cell proliferation and apoptosis. This suggested that mammary genes are coordinately regulated by miRNAs to make, package, and transport milk compositions.
Gene expression profiles in rat mammary gland at days 1 and 7 postpartum. To investigate the characteristics of the target genes of rat mammary gland miRNAs, the gene expression profiles in rat mammary glands at days 1 and 7 postpartum were analyzed simultaneously. More than 20 million clean reads were generated for each library. By using a cutoff of $0.01 RPKM to define potentially meaningful gene expression, there were 19,067 and 18,162 unique genes expressed at days 1 and 7 postpartum, respectively. Most of these genes (88%) were coexpressed at the 2 lactation time points. These gene sets and their RPKM values, identified by lactation stage, are provided in Supplemental Table 3 . The dynamic range of gene expression intensities covered several orders of magnitude: day 1 postpartum, 0.01-165,728.84 RPKM; day 7 postpartum, 0.01-190,608.54 RPKM.
The top 20 genes expressed at each stage are summarized in Table 2 . These genes accounted for 59% and 60% of the mammary gland mRNAs at days 1 and 7 postpartum, respectively. Notably, the top 3 expressed genes, Casein as2-like A (Csn1s2a), Casein as1 (Csn1s1), and Casein b (Csn2), which gave rise to major milk proteins, represented 41% and 46% of days 1 and 7 postpartum mammary gland mRNAs, respectively.
The functional clusters of the top 200 expressed genes in the 2 lactation stages were analyzed by using the DAVID platform (Supplemental Fig. 2 ). In the 2 lactation stages, highly expressed genes were involved in mRNA translation, ribosome biosynthesis, respiratory chain, and cellular protein localization and transport, etc. In other words, mammary genes were coordinately expressed to make and transport milk proteins and to generate the ATP required for this massive protein factory. The 2 lactation stages shared most of the enriched gene clusters, except for genes involved in cytoskeletal protein organization, which were enriched only in day 7 postpartum mammary glands.
Differentially expressed miRNAs across lactation stages. Correlation analysis between samples was used to assess the sample homogeneity before identification of the differentially expressed miRNAs and mRNAs. The correlation indexes between the 2 samples were 0.91 and 0.93 for miRNAs and mRNAs, respectively (P < 0.01).
Compared with day 1 postpartum, 27 miRNAs were differentially expressed (11 upregulated, 16 downregulated) at day 7 postpartum (Fig. 1) , the expression levels of the 27 miRNAs were further confirmed by qPCR ( Table 3) . rno-miR-30a-5p was 1 of the top 10 expressed miRNAs at day 1 postpartum.
The linear relation (on a log scale) between normalized RNAseq RPKM and qPCR DCt [(target gene, cycle threshold) -(geometric mean of endogenous genes, cycle threshold)] across all genes was strong (R 2 = 0.86, P < 0.01; Fig. 2 ). These PCR results confirmed our RNA-seq findings.
Differentially expressed miRNA target gene prediction. To further understand the physiologic functions and biologic processes involving these miRNAs during mammary gland development and lactation, target gene prediction was performed based on miRNA/mRNA interactions to provide some molecular insights into the process. A total of 8834 annotated mRNA transcripts were predicted to be putative target genes for the 27 differentially expressed miRNAs (Supplemental Table 4 ). 
FIGURE 1
Identification of differentially expressed miRNAs in lactating rat mammary glands at days 1 and 7 postpartum, as assessed by the edgeR program. DEG standard: P # 0.01; FC $2 or #0.5. The logConc provides the overall concentration for a gene across the 2 groups being compared; the cluster of points on the left side signifies that genes were observed in only 1 group of replicate samples. Each RNA sample is a pool of 5 mammary gland samples. DEG, differentially expressed gene; FC, fold-change; logConc, the log-average concentration/abundance for each RNA in the 2 groups being compared; miRNA, microRNA.
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Expression of putative target genes of differentially expressed miRNAs. A total of 1259 of the putative target genes were expressed in both mammary gland samples at the 2 time points, which accounted for 14% of the putative target genes. They were defined as mammary gland target genes (MTGs). Because the liver and mammary gland have complementary metabolic roles during lactation (24) , qPCR was used to compare the expression of 14 MTGs between these 2 organs. Most of the MTGs had similar expression profiles, except for insulin-induced gene 1 (Insig1), sterol regulatory element binding transcription factor 1 (Srebf1), lipoprotein lipase (Lpl), and aquaporin 3 (Aqp3). Interestingly, Insig1 and Srebf1 had opposite expression profiles in both the liver and the mammary gland, which was remarkably consistent with the observation that Insig1 inhibits Srebf1 (25) . These results further confirmed our RNA-seq findings.
Biologic function enrichment analysis of MTGs. The MTGs were enriched to 51 GO terms (Fig. 3) . One of the GO terms included 24 lipid metabolic process-related genes (FDR = 0.004), which were putative targets of 10 differentially expressed miRNAs. This suggested that the differentially expressed miRNAs identified in the present study might act as dominant regulators during rat lactation.
Discussion
Microarray analysis has identified 102 known mouse mammary gland miRNAs at days 5 and 10 postpartum (12) . In the present study, 445 known miRNAs were identified in the lactating rat mammary gland by RNA-seq, which included 100 mouse orthologs detected by Avril-Sassen et al. (12) . Many more miRNAs were identified than in the previous study in mice (12) . Similarly, 346 and 283 known miRNAs were identified through RNA-seq in the mammary gland of dairy goat and dairy cow, respectively (26, 27) .
Four of the top 10 highly expressed miRNAs in the lactating rat mammary gland were reported to be involved in adipocyte differentiation (Table 1) . miR-143, miR-21, and miR-146b, which account for >40% of the miRNAs expressed in lactating rat mammary gland, were shown to promote adipogenesis (28) (29) (30) . Ectopic expression of miR-143 accelerated the rate of adipocyte differentiation by downregulating pleiotrophin (a negative regulator of adipogenesis) and by upregulating many adipocyte-important genes at early stages of adipogenesis (28) . miR-21 targets TGF (b receptor II; Tgfbr2), decreasing both protein and mRNA levels of Tgfbr2, thereby enhancing adipogenic differentiation (29) . The other highly expressed miRNA, miR-146b, promotes adipogenesis via modulation of Sirtuin1, which subsequently downregulates the negative regulators of adipogenesis (30) . On the other hand, miR-145-5p expression during differentiation can inhibit adipogenesis by targeting the insulin receptor substrate 1 (31) . Interestingly, we observed that the expression of miR-143, miR-21, and miR-146b tended to decrease, and miR-145 tended to increase, at day 7 postpartum compared with day 1, which was accompanied by a decrease in the expressions of several genes involved in lipid synthesis. These results are consistent with the phenomenon that, shortly after parturition, adipocytes within the mammary glands of mice start to become depleted (32) . Given that adipocytes within the mammary gland can modulate the growth and function of the mammary epithelium (33) , it is tempting to speculate that these miRNA families might indirectly regulate milk synthesis. 1 Values are means 6 SEMs, n = 5.The relative expression levels of each differentially expressed miRNA were analyzed by real-time qPCR. miRNA, microRNA; DCt, change in cycle threshold; DDCt, DCt on day 7 2 DCt on day 1. 2 U6 small nuclear RNA was selected as the endogenous control gene for calculating the DCt of each miRNA as shown in second and third row. 3 DDCt values of miRNAs were calculated by DCt at day 7 postpartum subtracting that from the value at day 1 postpartum.
FIGURE 2
Correlation of mRNA gene expression differences in rat mammary glands at days 1 and 7 postpartum measured by RNA-seq compared with that by qPCR. b-actin was selected for endogenous control genes. RNA-seq data were derived from 2 pooled RNA samples (each from 5 different mammary gland samples obtained during lactation), real-time qPCR data were derived from 5 biologic replicates of mammary gland samples at the 2 different time points. Log2FC, log 2 RNA sequencing reads per kilobase per million mapped reads fold-change (day 7 postpartum compared with day 1 postpartum); RNA-seq, RNA sequencing; DCt, change in cycle threshold; DDCt, DCt on day 7 2 DCt on day 1.
Another 3 miRNAs, miR-26a, miR-30a, and miR-99a, are among the top 10 highly expressed miRNAs in the lactating mammary gland (Table 1) . These 3 miRNAs are involved in cell apoptosis. miR-26a represses cyclin D2 and cyclin E2, which play critical roles in transition through the G1-S checkpoint, and subsequently inhibits cancer cell proliferation and induces tumor-specific apoptosis (34) ; it also acts synergistically with miR-16 to target another 2 cell cycle regulators, checkpoint kinase 1 and WEE1 G2 checkpoint kinase, to increase apoptosis (35) . By contrast, miR-30 family members inhibit mitochondrial fission and consequent apoptosis (36) . miR-99a suppresses proliferation and promotes apoptosis by regulating the tacrolimus (FK506) binding protein 5 and insulin-like growth factor I receptor/mechanistic target of rapamycin signaling pathways (37) . The weight of evidence indicates that a change in mammary cell number, as a result of an imbalance between cell proliferation and cell removal, is a principal cause of declining milk production (38) . It suggests that the persistency of lactation and the rate of decline in milk yield with the stage of lactation are strongly influenced by the rate of cell death by apoptosis in the lactating gland (38) . In the present study, the TPM of miR-26a increased from 35,544 to 63,126, and miR-99a increased from 47,016 to 56,358, whereas that of miR-30a decreased from 21,028 to 11,811, which suggests that these miRNAs promote mammary epithelial cell apoptosis during lactation.
The balance between epithelial and mesenchymal cells in the mammary gland is crucial for the persistency of lactation, which is also coordinately regulated by miRNAs. Three of the top 10 expressed miRNAs in the present study, miR-99a, miR-99b, and miR-200b, were shown to regulate the epithelial to mesenchymal transition (EMT) ( Table 1) . Overexpression of mir-99a and mir-99b enhances epithelial to mesenchymal plasticity in normal murine mammary gland cells (39) . Enforced expression of the miR-200 family alone was sufficient to prevent TGF-b-induced EMT, whereas ectopic expression of these miRNAs in mesenchymal cells initiated mesenchymal to epithelial transition (40) . miR-200a is important for maintaining the epithelial cell phenotype, which contributes to lactogenic hormone induction of cellular differentiation in mammary glands (41) .
Another of the top 10 highly expressed miRNAs in the present study is miR-148b (Table 1) . Orthologs of miR-148 are also abundantly expressed in the lactating mammary gland of other mammal species, such as mouse, dairy goat, and dairy cow (12, 14, 27) ; however, its function in the mammary gland remains unclear. miRNA-148 can act as a fine-tuner in regulating the innate response and antigen-presenting capacity of dendritic cells, which may contribute to immune homeostasis and immune regulation (42) . Interestingly, orthologs of miR-148 are also abundant in milk exosomes of human (43) . Exosomes contain miRNAs that can be delivered to another cell, where the miRNAs could be functional (44) . Moreover, exosomes containing immune-related miRNAs in the colostrum are involved in modulating the bodyÕs immune response (45) . This suggests that miR-148b is secreted into milk and might subsequently enter into the body fluid of newborn offspring through breastfeeding, which likely facilitates immune development and maturation in infants.
miR-10a has been shown to participate in the control of ribosome biogenesis and global protein synthesis via the regulation of ribosomal protein (RP) mRNA translation (46) . The miR-10a-binding sites are conserved across mammalian species, and in contrast to the majority of experimentally determined miRNAbinding sites, miR-10a binds at the 5# untranslated region of RP mRNAs, and subsequently upregulates RP translation and ribosome biogenesis (46) . In the present study, the TPM value of mir10a decreased from 17,034 on day 1 to 14,496 on day 7. Meanwhile, the RPKM of most of the RP mRNAs (45 of 48) decreased from day 1 to day 7, with the total RPKM decreasing from 31,498 to 22,544 (Supplemental Table 5 ). This is consistent with a previous study in which the total protein concentration in day 7 milk was lower than that in day 1 (47) . Thus, we hypothesized that that miR-10a enhances the stability of RP mRNAs and provides more templates for translation in the mammary gland.
To investigate the importance of the remaining miRNAs expressed in the lactating mammary gland, we screened the differentially expressed miRNAs between lactation stages. By using a fold-change threshold value of 2, we identified 27 miRNAs that were differentially expressed between lactation stages ( Table 3 ). The miR-30 family has the highest abundance among the 27 miRNAs, which accounted for 77% and 89% of the miRNAs differentially expressed at days 1 and 7, respectively. In addition to the above-mentioned function of cell apoptosis regulation (36) , the miR-30 family is also involved in stimulation of adipogenesis. Inactivation of the miR-30 family impaired adipogenesis and overexpression of miR-30a and miR30d improved adipogenesis (48) . miR-7 reduces the expression of several oncogenes including epidermal growth factor receptor (EGFR), p21 protein (Cdc42/ Rac)-activated kinase 1 (PAK1), and IGF1R in human cancer tissues such as breast cancer (49) (50) (51) . In the present study, the expression of mir-7a decreased, and the expressions of Egfr, Pak1, and Igf1r increased, with the advance of lactation, which was highly consistent with the observations of previous works (49) (50) (51) . Moreover, a recent work indicated that mir-7 could inhibit EMT of breast cancer cells (52) . Because the mammary epithelium invades the stroma during mammary gland development in a process similar to that of cancer, mir-7 might participate in the regulation of the balance of epithelial and mesenchymal cells in the normal mammary gland.
Interestingly, the downregulated MTGs were enriched for the pathways that concern the lipid biosynthetic process. This is highly consistent with the observed 300% reduction in the concentration of fat (TGs) in rat milk during the first 5 d postpartum, which remains constant for the remaining 15 d (47) . By contrast, the daily total human milk fat output sharply increased by 21-fold from day 1 to day 4 and then continued to increase slowly, reaching a plateau of 40-fold by day 28 (53) . As expected, many genes representing all aspects of lipid metabolism and milk FA production, which include lipolysis at the mammary epithelial cell membrane, FA uptake from blood, intracellular FA transport, FA and glycerol activation, de novo FA synthesis, FA elongation, FA desaturation, synthesis of TGs, cholesterol synthesis and metabolism, and lipid droplet formation, are upregulated during the development of human lactation (53) . Most of the lipid synthesis genes that are upregulated during human lactation decreased during rat lactation in the present study, which further confirmed that milk lipid synthesis and secretion is a complex process requiring the orchestration of a wide variety of pathways (53) .
Moreover, 10 of the 27 differentially expressed miRNAs have MTGs involved in lipid synthesis and secretion. These include miR-133b-3p, miR-3582 (also called miR-133c), miR-134-5p, miR-190a-5p, miR-20a-3p, miR-23a-5p, miR-27a-5p, miR-3120, miR-451-5p, and miR-92a-1-5p. The miR-27 family has been shown experimentally to participate in mammary gland lipid metabolism (10) ; the function of the other miRNAs on lipid synthesis and secretion needs to be confirmed. miR-3582 has 7 MTGs including glucose-6-phosphate dehydrogenase (G6pd); aldehyde dehydrogenase 1 family, member A1 (Aldh1a1); stearoylCoA desaturase (Scd); stearoyl-coenzyme A desaturase 1 (Scd1); cytochrome P450, family 1, subfamily a, polypeptide 1 (Cyp1a1); FA synthase (Fasn); and estrogen-related receptor g (Esrrg). miR-3120 has 6 MTGs including steroid-5-a-reductase, a polypeptide 1 (Srd5a1), branched-chain amino acid transaminase 2 (Bcat2), thyroid hormone responsive (Thrsp), betaine-homocysteine Smethyltransferase 2 (Bhmt2), phosphate cytidylyltransferase 2, ethanolamine (Pcyt2), and solute carrier family 27, member 1 (Slc27a1). Some of these MTGs, such as Scd, Scd1, Fasn, Esrrg, and Thrsp, have been shown to be involved in lipid metabolism. This suggests that the differentially expressed miRNAs identified in the present study might play a dominant role in the regulation of lipid metabolism.
